Magellan Health (MGLN) Tops Q4 EPS Expectations

Magellan Health (NASDAQ: MGLN) reported Q4 EPS of $1.39, $0.56 better than the analyst estimate of $0.83. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.22 billion.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• Colony Bankcorp to acquire First Reliance in $163M stock-and-cash deal
• ICON plc (ICLR) PT Raised to $150 at BofA Securities